← All trials
NCT01310738
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2011
- Primary completion
- Oct 1, 2014
- Completion date
- Feb 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 380
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- University of BrasiliaLead sponsor
- State University of Montes ClarosOverall official - principal investigator
- Federal University of PiauiOverall official - principal investigator
- Hospital Infantil Joao Paulo II - FHEMIGOverall official - principal investigator
- Federal University of SergipeOverall official - principal investigator
- University of BrasiliaStudy chair
- Conselho Nacional de Desenvolvimento Científico e TecnológicoCollaborator
- University of BrasiliaReponsible party - principal investigator
- Drugs for Neglected Diseases InitiativeStudy director
- Drugs for Neglected Diseases InitiativeCollaborator
- Government of BrazilCollaborator
- Federal University of Minas GeraisOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.